Biomedical Engineering Reference
In-Depth Information
33. Li, S.D., and L. Huang, Targeted delivery of antisense oligodeoxynuc-
leotide and small interference RNA into lung cancer cells.
Mol Pharm
,
(5): pp. 579-588.
34. Matsumura, Y., and H. Maeda, A new concept for macromolecular
therapeutics in cancer chemotherapy: mechanism of tumoritropic
accumulation of proteins and the antitumor agent smancs.
2006.
3
Cancer Res
,
(12 Pt 1): pp. 6387-6392.
35. Jeffs, L.B.,
1986.
46
, A scalable, extrusion-free method for efficient liposomal
encapsulation of plasmid DNA.
et al.
Pharm Res
, 2005.
22
(3): pp. 362-372.
36. Yu, W.,
, A sterically stabilized immunolipoplex for systemic
administration of a therapeutic gene.
et al.
Gene Ther
, 2004.
11
(19):
pp. 1434-1440.
37. Morrissey, D.V.,
et al.
, Potent and persistent
in vivo
anti-HBV activity
of chemically modified siRNAs.
Nat
Biotechnol
, 2005.
23
(8):
pp. 1002-1007.
38. Zimmermann, T.S.,
et al.
, RNAi-mediated gene silencing in non-human
primates.
Nature
, 2006.
441
(7089): pp. 111-114.
39. Geisbert, T.W.,
, Postexposure protection of non-human primates
against a lethal Ebola virus challenge with RNA interference: a proof-
of-concept study.
et al.
(9729): pp. 1896-1905.
40. Podesta, J.E., and K. Kostarelos, Chapter 17 — Engineering cationic
liposome siRNA complexes for
Lancet
, 2010.
375
in vitro
and
in vivo
delivery.
Methods
Enzymol
, 2009.
464
: pp. 343-354.
41. Buyens, K.,
, Elucidating the encapsulation of short interfering
RNA in PEGylated cationic liposomes.
et al.
Langmuir
, 2009.
25
(9):
pp. 4886-4891.
42. Shi, N., R.J. Boado, and W.M. Pardridge, Receptor-mediated gene
targeting to tissues
following intravenous administration of
pegylated immunoliposomes.
in vivo
Pharm Res
, 2001.
18
(8): pp. 1091-1095.
43. Maurer, N.,
, Spontaneous entrapment of polynucleotides upon
electrostatic interaction with ethanol-destabilized cationic liposomes.
Biophys J
et al.
(5): pp. 2310-2326.
44. Stuart, D.D., and T.M. Allen, A new liposomal formulation for antisense
oligodeoxynucleotides with small size, high incorporation efficiency
and good stability.
, 2001.
80
Biochim Biophys Acta
, 2000.
1463
(2): pp. 219-229.
45. Wu, S.Y.,
, Systemic delivery of E6/7 siRNA using novel lipidic
particles and its application with cisplatin in cervical cancer mouse
models.
et al.
(1): pp. 14-22.
46. Cristofaro, P., and B. Ramratnam, RNAi tackles a sexually transmitted
disease.
Gene Ther
, 2011.
18
Nat Biotechnol
, 2006.
24
(1): pp. 48-49.
Search WWH ::
Custom Search